Fortitude Family Office »

Amneal Pharmaceuticals shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.9k 966 6.06
2023-12-31 $5.9k 966 6.07

More positions owned by Fortitude Family Office

Apple Stock (AAPL)
Ishares Core S&p 500 Etf Etf (IVV)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Wisdomtree Floating Rate Treasury Fund Etf (USFR)
Vanguard Mid-cap Etf Etf (VO)
Ishares Tips Bond Etf Etf (TIP)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Ishares Core S&p Small Cap Etf Etf (IJR)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Jpmorgan Ultra-short Income Etf Ultra Short Income Fund Etf (JPST)
Kkr & Co Stock (KKR)
Ishares Core S&p Mid-cap Etf Etf (IJH)
Ishares Msci Emerging Markets Ex China Etf Etf (EMXC)
Vanguard Ftse Emerging Markets Etf Etf (VWO)

View all positions for Fortitude Family Office

Top funds holding Amneal Pharmaceuticals

Vanguard Group
Tpg Gp A
Fosun International
Rubric Capital Management
BlackRock
Citadel Advisors
Neuberger Berman Group
Dimensional Fund Advisors
Geode Capital Management
Nantahala Capital Management
Nuveen Asset Management
BlackBarn Capital Partners
Northern Trust
Charles Schwab Investment Management
LSV Asset Management

View all funds holding Amneal Pharmaceuticals